Learn / IOVA
NASDAQ: IOVA
Iovance Biotherapeutics (IOVA) stock, explained like you're 5
Iovance Biotherapeutics trades on the Nasdaq under the ticker IOVA. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 6.6 billion dollars.
- Ticker
- IOVA
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Mid cap, about 6.6 billion dollars
Is Iovance Biotherapeutics a small, medium or large cap company?
No. Iovance Biotherapeutics is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 6.6 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Iovance Biotherapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves IOVA stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Why Did IOVA, AMLX And COP Stocks Surge To 52 Week Highs Today? (Stocktwits)
- Trading the Move, Not the Narrative: (IOVA) Edition (Stock Traders Daily)
- Iovance Biotherapeutics (IOVA) Stock Trades At A Premium As Shares Jumped 421% (Simply Wall Street)
- Why Iovance Biotherapeutics (IOVA) Stock Is Down Today (Quiver Quantitative)
- IOVA Stock Pulls Back As Traders Eye Biotech Momentum (StocksToTrade)
Follow IOVA in your daily brief
Each trading day at 5 PM ET we post what happened to Iovance Biotherapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow IOVA
Questions about Iovance Biotherapeutics stock
What does Iovance Biotherapeutics do?
Iovance Biotherapeutics trades on the Nasdaq under the ticker IOVA. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 6.6 billion dollars.
What is the ticker symbol for Iovance Biotherapeutics?
Iovance Biotherapeutics trades under the ticker IOVA on the Nasdaq.
What is Iovance Biotherapeutics's market cap?
Iovance Biotherapeutics is a mid cap stock with a market cap of about 6.6 billion dollars.
How does Iovance Biotherapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves IOVA stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow IOVA stock every day?
Add IOVA to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.